Drylief SUD 1%0.4 ml

Established / OTC-Labeled Uses

• Relief of dry eye symptoms: Drylief SUD 1% ophthalmic solution is indicated for the temporary relief of burning, irritation, and discomfort due to dryness of the eye, and for use as a protectant against further irritation.
• Ocular lubricant: Drylief SUD 1% is used as a lubricant for the relief of dryness associated with exposure to wind or sun, and to help prevent further irritation from occurring.
• Contact lens wear: Drylief SUD 1% eye drops may be used to relieve dryness and discomfort associated with contact lens wear, and some formulations are specifically indicated for use as a rewetting/lubricating drop for both soft and rigid gas-permeable lenses.

Drylief SUD 1% is an over-the-counter artificial tear product; it does not treat the underlying cause of dry eye and is intended for symptomatic relief only. Persistent or worsening symptoms should be evaluated by a physician.

Carboxymethylcellulose Sodium ophthalmic solution is available in various strengths depending on the manufacturer and product line, commonly ranging from about 0.25% to 1% (e.g., 0.5%, 1%) Carboxymethylcellulose Sodium, formulated as sterile eye drops with or without preservative (preservative-free single-use vials are also available). Some combination products contain Carboxymethylcellulose Sodium together with glycerin or other lubricating agents. Confirm the exact strength and formulation on the specific product label.

Drylief SUD 1% is a water-soluble cellulose derivative (a semi-synthetic polymer) widely used in ophthalmic preparations as a viscosity-enhancing, lubricating, and demulcent agent. When instilled in the eye, Drylief SUD 1% forms a thin, uniform film over the ocular surface that helps to stabilize the tear film, retain moisture, and reduce friction between the eyelid and the cornea/conjunctiva during blinking. Drylief SUD 1% is available as an over-the-counter artificial tear/lubricant eye drop, used for the symptomatic relief of dry eye and ocular irritation.

Ophthalmic lubricant / artificial tear preparation (viscosity-enhancing agent); Drylief SUD 1% belongs to the class of demulcent, tear-film-stabilizing agents used in ocular surface disease.

Carboxymethylcellulose Sodium is a hydrophilic, high-molecular-weight cellulose polymer that, when applied topically to the eye, increases the viscosity of the tear film and adheres to the ocular surface (mucin layer of the cornea and conjunctiva), prolonging its residence time compared with a simple saline solution. This viscosity-enhancing and mucoadhesive action helps to stabilize the pre-corneal tear film, reduce tear evaporation, and provide a protective, lubricating layer that relieves the burning, stinging, and foreign-body sensation associated with dry eye. Carboxymethylcellulose Sodium is not absorbed to a clinically relevant extent following topical ophthalmic instillation and exerts a purely local, physical/mechanical lubricating effect rather than a pharmacological one.

Drylief SUD 1% is for topical ophthalmic (eye) use only and must not be injected or taken by mouth. To administer: wash hands, tilt the head back, gently pull down the lower eyelid to form a small pocket, and instill the prescribed number of drops without letting the tip of the container touch the eye, eyelid, fingers, or any other surface, to avoid contamination. If wearing contact lenses, follow the specific product instructions regarding whether lenses should be removed before instillation. If using more than one topical eye medication, wait at least 5-10 minutes between different products to avoid one washing out the other.

Because Drylief SUD 1% ophthalmic solution acts locally on the ocular surface with negligible systemic absorption, clinically significant systemic drug interactions have not been established. The main interaction of practical relevance is local: if Drylief SUD 1% is instilled at the same time as another topical ophthalmic medication, it may dilute or wash out the other product, reducing its effectiveness. To avoid this, separate the instillation of Drylief SUD 1% from other eye drops by at least 5-10 minutes. There is no known food interaction, as Drylief SUD 1% eye drops are not ingested.

Common

• Transient blurred vision immediately after instillation (usually resolves within a few seconds to a couple of minutes as the drop settles)
• Mild, transient stinging, burning, or irritation on instillation

Less Common

• Eye discomfort, foreign-body sensation, or matting/crusting of the eyelids
• Local hypersensitivity reactions (redness, itching, swelling of the eyelid) in sensitive individuals, particularly with preserved formulations

Drylief SUD 1% ophthalmic solution is generally very well tolerated overall, reflecting its favorable local safety profile as an over-the-counter lubricant. Persistent eye pain, marked redness, vision changes, or worsening irritation should prompt discontinuation and medical evaluation.

Drylief SUD 1% ophthalmic solution has not been specifically studied in controlled trials in pregnant or breastfeeding women; however, because it is applied topically to the eye and has negligible systemic absorption, the risk of harm to the fetus or nursing infant is considered very low. As with any medication, Drylief SUD 1% should be used during pregnancy or breastfeeding only if clearly needed, and a physician should be consulted if there is any uncertainty, particularly if a preserved formulation is used or if the product contains additional active ingredients.

Topical/ophthalmic use only: Drylief SUD 1% eye drops are for external use in the eye only and should never be injected or swallowed.

Avoid contamination: Do not touch the dropper tip to the eye, eyelid, fingers, or any surface, as this may contaminate the solution and lead to eye infection. Discard any solution that has changed color or become cloudy.

Contact lens wearers: Contact lens wearers should follow the specific product instructions, as some formulations should not be instilled while lenses are in place, or require lens removal beforehand; consult the product label or an eye care professional.

When to seek medical care: If eye pain, changes in vision, continued redness or irritation of the eye, or if the condition worsens or persists for more than 72 hours, discontinue use and consult a physician rather than continuing self-treatment, as this may indicate a condition requiring specific medical evaluation.

Preservative sensitivity: Patients sensitive to preservatives (e.g., benzalkonium chloride) in multi-dose formulations should consider preservative-free, single-use preparations of Drylief SUD 1% if irritation occurs.

Ocular overdose with Drylief SUD 1% is unlikely to cause serious harm given its local mechanism and negligible systemic absorption; instilling more drops than recommended may simply cause temporary blurred vision or mild ocular irritation, which typically resolves without specific treatment. If Drylief SUD 1% solution is accidentally swallowed in significant quantity, or if a serious reaction occurs, seek immediate medical attention or contact a poison control center/emergency services for guidance rather than attempting specific home treatment.

Store at room temperature (below 30°C), away from light and moisture. Keep out of reach of children. Multi-dose bottles should be tightly closed after each use and discarded per the period stated on the product label (commonly within 4-6 weeks of opening) to prevent contamination; single-use preservative-free vials should be discarded immediately after first use, even if solution remains.

Renal impairment: No dose adjustment is required, as Drylief SUD 1% eye drops act locally with negligible systemic absorption.

Hepatic impairment: No dose adjustment is required for the same reason.

Elderly: Drylief SUD 1% may be used in elderly patients without specific dose adjustment; this population commonly experiences dry eye and may benefit from regular use as directed.

Pediatric patients: See Pediatric Uses.

Drylief SUD 1% may be used on an as-needed, ongoing basis for chronic dry eye symptom relief, or intermittently for occasional dryness/irritation (e.g., related to wind, sun, screen use, or contact lens wear). If symptoms do not improve, worsen, or persist beyond 72 hours of regular use, discontinue and consult a physician, as an underlying condition may require specific evaluation and treatment beyond simple lubrication.

Ophthalmic lubricants; artificial tear preparations; ocular demulcents/viscosity-enhancing agents.

Carboxymethylcellulose Sodium is a hydrophilic cellulose polymer that increases tear film viscosity and binds to the mucin layer of the ocular surface, prolonging tear film residence time, stabilizing the pre-corneal tear film, and providing a protective, lubricating coating over the cornea and conjunctiva. This physical/mechanical action relieves dryness, burning, and irritation without a systemic pharmacological effect.

Drylief SUD 1% ophthalmic solution is generally considered safe for use in children for the relief of dry eye or ocular irritation, given its local action and negligible systemic absorption; however, formal controlled pediatric safety and efficacy studies are limited, so use in young children should be guided by a pediatrician or eye care professional, with attention to correct administration technique to avoid contamination or accidental ingestion.